Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKRD39, or ankyrin repeat domain-containing protein 39, is a member of the ankyrin repeat domain protein family, characterized by repeating structural motifs that typically mediate protein-protein interactions[1][2]. Its gene is expressed in many tissues, but its function is largely inferred based on domain architecture and broad interaction networks rather than defined enzymatic activity or receptor function[1][5][6]. Recent transcriptomic studies in Alzheimer’s disease suggest ANKRD39 may operate as a hub gene influencing autophagy and intracellular signaling, but mechanistic details remain unclear[1]. While ankyrin repeat domains generally serve as scaffolds or adaptors in numerous cellular processes, ANKRD39 itself is not directly implicated as a receptor, enzyme, transporter, nor does it have established roles in other well-characterized molecular families[2]. Current research highlights its context-specific associations rather than direct therapeutic actions, and further experimental work is needed to define its functional role and any disease contribution[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing protein 39 (ANKRD39).